- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05269368
Interest of Wicking for Ossicular Surgery and Myringoplasty (MECH-ORL)
Intérêt du méchage Pour la Chirurgie Ossiculaire et la Myringoplastie : Essai contrôlé randomisé Multicentrique de Non-infériorité
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Myringoplasties and ossicular surgery are very common procedures. Following these otological surgeries, most surgeons install a wicking. This intervention consists of placing a wick, absorbable or not, in the external acoustic meatus, after having replaced the tympanomeatal flap.
Putting in place a wicking often requires to remove this wicking, feared by the patient. In addition, wicking leads to obstruction of the external acoustic meatus responsible for functional discomfort (feeling of fullness in the ear, pain, significant conductive deafness) which can last from one to several weeks depending on the type of wicking.
Despite these drawbacks, the rationale for wicking has never been established, the choice of wick type is often empirical, and its necessity is sometimes controversial in the literature. Recent studies have studied the absence of wicking as an alternative to overcome its many drawbacks. No prospective, randomized, multicenter study has been performed to show the superiority of wicking in healing following middle ear surgery (myringoplasty, stapedo-vestibular ankylosis, ossiculoplasty) via the duct or the endaural route. The only study with a high level of evidence concerns only endoscopic surgery. This study has the advantage of showing that with comparable audiometric and healing results, the absence of wicking allows a reduced operating time, an earlier reduction in otorrhea and the feeling of blocked ears, and an earlier improvement of hearing. Given this work in the literature, our hypothesis is that tympanic healing is not impaired in the absence of wicking.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Wiebe de JONG, MSc
- Phone Number: +33247474680
- Email: w.dejong@chu-tours.fr
Study Contact Backup
- Name: Charles AUSSEDAT, MD
- Phone Number: 74518 +33247474747
- Email: c.aussedat@chu-tours.fr
Study Locations
-
-
-
Blois, France, 41000
- Recruiting
- Hospital Blois
-
Contact:
- Charles-Edouard ROUF, MD-PhD
- Phone Number: +33254556525
- Email: charles.rouf@outlook.com
-
Brest, France, 29200
- Active, not recruiting
- University Hospital Brest
-
Le Mans, France, 72037
- Recruiting
- Hospital Le Mans
-
Contact:
- Catherine BOBIN, MD-PhD
- Phone Number: +33243434325
- Email: catherinebobin@gmail.com
-
Nantes, France, 44000
- Recruiting
- University Hospital Nantes
-
Contact:
- Guillaume MICHEL, MD-PhD
- Phone Number: +33240083475
- Email: guillaume.michel@chu-nantes.fr
-
Paris, France, 75013
- Recruiting
- Hospital La Pitié Salpêtrière-APHP
-
Contact:
- Daniele BERNARDESCHI, MD-PhD
- Phone Number: +33142177440
- Email: daniele.bernardeschi@aphp.fr
-
Tours, France, 37044
- Recruiting
- university hospital Tours
-
Contact:
- Charles AUSSEDAT, MD-PhD
- Phone Number: +33218370523
- Email: c.aussedat@chu-tours.fr
-
Contact:
- David BAKHOS, MD-PhD
- Phone Number: +33218370523
- Email: Bakhos.David@gmail.com
-
Sub-Investigator:
- David BAKHOS, MD-PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patient (age 18 = or + ), whose mother tongue is French or who understands French language
- Ossicular surgery (fitting of a partial or total ossicular prosthesis) or myringoplasty performed endoscopically, from the speculum, from the duct or from the endaural.
- Tympanic reconstruction by all types of grafts: cartilage, fascia, autologous fat
- Written consent signed by the participant
- Affiliation to a social security scheme,
Exclusion Criteria:
- Pregnant or breastfeeding woman, patient under legal protection, guardianship or curatorship.
- Need for a retroauricular approach.
- Need for annulus detachment> 60%
- Presence of cholesteatoma or middle ear tumor
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: No wicking
Absence of Wicking after intervention
|
No wicking after surgery
|
|
Active Comparator: Control
Wicking after intervention
|
Absorbable or non-absorbable wicking
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tympanic and external auditory canal healing
Time Frame: Three months after intervention.
|
Healing of tympanic membrane and external auditory canal, evaluated blindly by 3 experts, on an oto-endoscopy picture.
|
Three months after intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Audiometric results
Time Frame: Pre-operative, 3 months, 12 months
|
Audiometric results defined by the pure-tone average on 500, 1000, 2000 and 3000 Hz frequencies.
|
Pre-operative, 3 months, 12 months
|
|
Post-operative satisfaction
Time Frame: Immediate post-operative, day 7-10, day 30, 3 months
|
Visual Analogic scale (0-10 (min-max))
|
Immediate post-operative, day 7-10, day 30, 3 months
|
|
Post-operative pain
Time Frame: Immediate post operative,day 7-10, day 30, 3 months
|
Visual Analogic scale (0-10 (min-max))
|
Immediate post operative,day 7-10, day 30, 3 months
|
|
Post-operative quality of life
Time Frame: Day 7-10, day 30, 3 months,12 months
|
Glasgow Benefit Inventory (-100 (min) to +100 (max))
|
Day 7-10, day 30, 3 months,12 months
|
|
Post-operative stress
Time Frame: Pre-operative, day 7-10, day 30, 3 months, 12 months
|
Perceived Stress Scale (PSS-10) 10-50 (min-max) Never to often
|
Pre-operative, day 7-10, day 30, 3 months, 12 months
|
|
Operative time
Time Frame: 30-120 minutes
|
Operative time of the otology surgery, in minutes
|
30-120 minutes
|
|
Complications
Time Frame: At any time of the follow-up,up to 1 year
|
Questionnaire given to surgeons, allowing description of complications
|
At any time of the follow-up,up to 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Charles AUSSEDAT, MD, University hospital of Tours
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DR210132-MECH-ORL
- 2021-A02788-33 (Registry Identifier: Id-RCB-ANSM-France)
- 221 A15 (Other Identifier: Comité de Protection des Personnes Sud-Méditerranée II)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Op Complication
-
Rigshospitalet, DenmarkCompletedComplication,Postoperative | Post-Op ComplicationDenmark
-
Cairo UniversityNot yet recruiting
-
Riphah International UniversityCompletedPost-Op ComplicationPakistan
-
Alexa CraigMaineHealthCompletedPost-Op ComplicationUnited States
-
University of Alabama at BirminghamCompletedPost-Op ComplicationUnited States
-
Future University in EgyptRecruitingPost-Op ComplicationEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedPost-Op ComplicationFrance
-
NYU Langone HealthCompleted
-
Rothman Institute OrthopaedicsUnknown
-
Assiut UniversityCompleted
Clinical Trials on No wicking
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
University of California, San FranciscoNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitationColorectal Cancer | Colon Cancer | Cancer ColorectalUnited States
-
RadiancyCompletedMild to Moderate Chronic Low Back PainIsrael
-
The Hong Kong Polytechnic UniversityRecruitingChronic Low Back PainHong Kong
-
Royal Brompton & Harefield NHS Foundation TrustRecruitingIdiopathic Pulmonary Fibrosis (IPF) | Progressive Pulmonary FibrosisUnited Kingdom
-
National Taiwan University HospitalNot yet recruitingThe Cardiac Function
-
University of IoanninaEnrolling by invitationCarpal Tunnel Syndrome (CTS)Greece
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
Marmara UniversityCompleted
-
RTI InternationalNo Means No WorldwideCompleted